一个双向的分子用于疾病可激活的蛋白解向金马和向的放射性核酸治疗癌症
Yuan Zhang1,2, Wei Gu2, Wan Chen2
1School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China.
Journal of the American Chemical Society
|February 24, 2025
概括
这项研究引入了双重向的治疗探针,将PROTAC与前列腺癌的放射性核化物治疗结合起来. 这些探针提高了特异性和有效性,为改善癌症治疗提供了有前途的方法.
科学领域:
- 癌症学
- 生物技术
- 放射化学
背景情况:
- 在癌症治疗中,蛋白质溶解向基因组 (PROTACs) 是有前途的,但其药理动力学和特异性较差.
- 有针对性的放射性核酸治疗 (TRT) 是有效的,但由于输送和非目标效应而受到限制.
研究的目的:
- 开发用于治疗前列腺癌的双单分子神经探针.
- 将可激活疾病的PROTAC与TRT结合起来,以提高特异性和疗效.
- 克服现有的 PROTAC 和 TRT 方法的局限性.
主要方法:
- 设计和合成双准的天文探测器 (Lu-P-A和Lu-P-A).
- 在BRD4降解中加入一种可激活的cathepsin B (CTSB) 亲PROTAC.
- 使用前列腺特异性膜抗原 (PSMA) 针对基于Lu的TRT.
主要成果:
- 这些探针显示出高瘤成像特异性和由于PSMA向治疗剂的积累.
- 激活PROTAC导致BRD4降解,降低RAD51AP1的调节,并增强TRT的疗效.
- 联合治疗显示出协同效应,比单独治疗更有效地促进细胞亡.
- 观察到高清和生物安全性,表明临床转化潜力.
结论:
- 通过结合PROTAC和TRT,双重向的治疗探针提供了精确有效的前列腺癌治疗策略.
- 这种方法克服了免费PROTAC的局限性,并通过协同效应提高治疗效果.
- 开发的探针显示出在精密瘤学中的临床转化潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K